223 related articles for article (PubMed ID: 19667272)
21. SOX1 Antibody in a Patient With Serotonin Syndrome.
Hoffer J; Frem W; Alkana J; Chih C; Liu AK
Cureus; 2023 Nov; 15(11):e48516. PubMed ID: 37946854
[TBL] [Abstract][Full Text] [Related]
22. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
23. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
[TBL] [Abstract][Full Text] [Related]
24. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
25. SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma.
Sun Y; Zhang R; Wang M; Zhang Y; Qi J; Li J
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2043-7. PubMed ID: 22832207
[TBL] [Abstract][Full Text] [Related]
26. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
27. Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome.
Sun X; Tan J; Sun H; Liu Y; Guan W; Jia J; Wang Z
J Clin Neurol; 2020 Oct; 16(4):530-546. PubMed ID: 33029958
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 Antibodies.
Wada S; Kamei M; Uehara N; Tsuzaki K; Hamano T
Intern Med; 2021 May; 60(10):1607-1610. PubMed ID: 33328403
[TBL] [Abstract][Full Text] [Related]
29. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of anti-SOX1 reactivity in various neurological disorders.
Berger B; Dersch R; Ruthardt E; Rasiah C; Rauer S; Stich O
J Neurol Sci; 2016 Oct; 369():342-346. PubMed ID: 27653921
[TBL] [Abstract][Full Text] [Related]
31. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.
Feldheim J; Deuschl C; Glas M; Kleinschnitz C; Hagenacker T
Neurol Res Pract; 2021 May; 3(1):30. PubMed ID: 34030742
[TBL] [Abstract][Full Text] [Related]
33. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
34. Anti-SOX1 antibodies-positive paraneoplastic neurological syndromes caused by thyroid carcinoma: A case report.
Deng Y; Zhang X; Wang L; Lu X; Gao Y; Wu Z; Zhong Z
Medicine (Baltimore); 2023 Apr; 102(16):e33499. PubMed ID: 37083806
[TBL] [Abstract][Full Text] [Related]
35. Small cell lung cancer: Novel treatments beyond immunotherapy.
Meijer JJ; Leonetti A; Airò G; Tiseo M; Rolfo C; Giovannetti E; Vahabi M
Semin Cancer Biol; 2022 Nov; 86(Pt 2):376-385. PubMed ID: 35568295
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic neurological syndromes: clinical presentations and management.
Devine MF; Kothapalli N; Elkhooly M; Dubey D
Ther Adv Neurol Disord; 2021; 14():1756286420985323. PubMed ID: 33796141
[TBL] [Abstract][Full Text] [Related]
37. Coexistence of Anti-SOX1 and Anti-GABA
Qin W; Wang X; Yang J; Hu W
Clin Interv Aging; 2020; 15():171-175. PubMed ID: 32103919
[TBL] [Abstract][Full Text] [Related]
38. Emerging therapies for small cell lung cancer.
Yang S; Zhang Z; Wang Q
J Hematol Oncol; 2019 May; 12(1):47. PubMed ID: 31046803
[TBL] [Abstract][Full Text] [Related]
39. SOX-1 antibodies positive Lambert-Eaton myasthenic syndrome with occult small cell lung cancer: A case report.
Zhao L; He H; Han W; Meng Y; Kang L; Chen Y
Clin Respir J; 2024 Mar; 18(3):e13740. PubMed ID: 38497229
[TBL] [Abstract][Full Text] [Related]
40. Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.
Jean MJ; Samkoff L; Mohile N
Curr Treat Options Oncol; 2024 Jan; 25(1):42-65. PubMed ID: 38198120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
